Transformative Targeted Therapies
Bothell, Washington
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been accepted by the U.S. FDA; IM-1021, a clinical-stage ROR1 ADC; IM-1617, a clinical-stage solid tumor ADC; and IM-3050, a clinical-stage FAP-targeted radioligand therapy. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets.
On-site · Balmoral
Achieve territory sales objectives for varegacestat by developing account plans, delivering compliant clinical and value-based messages, and building trusted relationships with healthcare providers and local oncology stakeholders. Collaborate with Market Development, Marketing, Market Access, and Medical Affairs, while sharing territory insights and maintaining accurate, compliant sales documentation.